Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Interventional, Controlled Study To Assess The Performance And Tolerance Of Pixel CO2-Alma Fractionated Laser in Women Affected by GenitoUrinary Syndrome of Menopause (GSM)

NCT05156502 is registered in ClinicalTrials.gov with Dr. Filippo Murina as lead sponsor.

NCT NCT05156502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05156502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Interventional, Controlled Study To Assess The Performance And Tolerance Of Pixel CO2-Alma Fractionated Laser in Women Affected by GenitoUrinary Syndrome of Menopause (GSM)
Lead sponsor
Dr. Filippo Murina
Phase
Not applicable
Overall status
Unknown status
Start date
January 30, 2022
Completion date
August 31, 2022
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burning, dyspareunia, dysuria, genitourinary syndrome of menopause (gsm), pain, vaginal dryness